Table 9. Characteristics of clinical trials studying losartan in patients with COVID-19.
| Clinical trial ID | Status | Study results | Conditions | Interventions | Locations |
| NCT04330300 | Recruiting | No results available | Hypertension, COVID-19 | Drug: ACE inhibitor other antihypertensive agents | Ireland |
| NCT04340557 | Recruiting | No results available | COVID-19 | Losartan | United States |
| NCT04335786 | Recruiting | No results available | COVID-19 | Drug: Valsartan (diovan) drug: Placebo oral tablet | Netherlands |
| NCT04312009 | Recruiting | No results available | COVID-19 | Drug: Losartan other: Placebo | United States |
| NCT04311177 | Recruiting | No results available | COVID-19 | Drug: Losartan other: Placebo | United States |
| NCT04328012 | Recruiting | No results available | COVID-19 | Drug: Lopinavir/ritonavir Drug: Hydroxychloroquine Sulfate Drug: Losartan | United States |